产品展示
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
点击次数：238发布时间：2012/11/6 20:59:40
更新日期：2024/10/16 16:00:55
所 在 地：美洲
产品型号：
优质供应
详细内容
慧嘉生物您实验身边的好伙伴
为客户提供“品质的产品”和“*优质的服务”
AssayBiotech CUSABIO Immunoway Santa Abcam Cst jackson Pierce Sigma Amresco Qiagen Cayman abnova millipore invitrogen merk ebioscience prospec
欢迎广大客户咨询，另有大量宣传海报和小礼品赠送。
Q Q：
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
Introduction H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. Description Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. Inactivation Thimerosal ａnd beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. Physical Appearance Sterile Filtered colorless solution. Formulation The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. Stability A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C.
Please prevent freeze-thaw cycles. Immunological Activity Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA. Purity Greater than 90.0% as determined by SDS-PAGE. Usage ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
H3N2 Wisconsin/ 甲型流感病毒H3N2病毒Wisconsin 67/05
产品编号：IHA-023
产品规格：10μg/50μg/1mg
产品规格：10μg/50μg/1mg
| Introduction | H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin（H） ａnd neuraminidase（N）. H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, ａnd influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. |
| Description | Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. |
| Inactivation | Thimerosal ａnd beta propiolactone treatment This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices ａnd techniques are required at work. |
| Physical Appearance | Sterile Filtered colorless solution. |
| Formulation | The H3N2 A/Wisconsin/67/05solution contains STE, 0.1 % sodium azide （NaN3） ａnd 0.005 % thimerosal. |
| Stability | A/Wisconsin/67/05 although stable 4°C for 4 weeks, should be stored desiccated below -18°C. Please prevent freeze-thaw cycles. |
| Immunological Activity | Serological studies of influenza A virus, immunogen for antibody production. Tested with anti-influenza A monoclonal antibodies in ELISA. |
| Purity | Greater than 90.0% as determined by SDS-PAGE. |
| Usage | ProSpec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals. |
